RxSight financial statements
RX사이트NASDAQ:RXST · Nasdaq · Healthcare$4.80+3.23%
2026-10-07 close · prelimRxSight's published financial data is dated 2026-10-04. 2024 revenue was $140M. 2024 operating profit was −$37M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy